IMA Worldwide Launches Enterprise AI Adoption Framework Built on 40 Years of AIM Research Durham, United States - July ...
Highlights FDA End-of-Phase 2 (EOP2) meeting minutes confirmed a registrational pathway for ATH434 in Multiple System Atrophy (MSA)FDA agreed that a single pivotal Phase 3 trial plus confirmatory evid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results